<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="Publisher" Owner="NLM">        <PMID Version="1">30389437</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>03</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1532-8392</ISSN>                <JournalIssue CitedMedium="Internet">                    <PubDate>                        <Year>2018</Year>                        <Month>Oct</Month>                        <Day>30</Day>                    </PubDate>                </JournalIssue>                <Title>Human pathology</Title>                <ISOAbbreviation>Hum. Pathol.</ISOAbbreviation>            </Journal>            <ArticleTitle>Immunohistochemical profiles in primary lung cancers and epithelial pulmonary metastases.</ArticleTitle>            <ELocationID EIdType="pii" ValidYN="Y">S0046-8177(18)30396-4</ELocationID>            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.humpath.2018.10.009</ELocationID>            <Abstract>                <AbstractText>Correct diagnosis of pulmonary tumors is essential for treatment decision and often rely on immunohistochemical markers. We stained tissue microarrays from resected primary lung cancer (n=665) and pulmonary metastases (n=425) for CK7, CK20, CDX2, CK5, p40, p63, TTF-1, napsin A, GATA3 and PAX8 to systematically assess the diagnostic value of these markers. Primary lung adenocarcinomas expressed TTF-1 in 90% and napsin A in 84% of the cases, while 10% were positive for p63, 7% for CDX2, 2% for CK20 and 2% for GATA3. Only 68% of the lung adenocarcinomas were positive for CK7, TTF-1 and napsin A and negative for all other markers. Primary lung squamous cell carcinomas expressed CK5, p40 and p63 in 94-97% of cases, while 44% were positive for CK7, 20% for GATA3, 7% for CDX2 and 3% for TTF-1. Rare cases expressed PAX8, CK20 or napsin A. Pulmonary metastases of colorectal cancer were positive for CK20 in 83% and CDX2 in 99% of the cases. Rare cases expressed CK7, p63 or PAX8, while 4% expressed TTF-1. Pulmonary metastases of renal cell carcinomas were positive for PAX8 in 74%, napsin A in 7% and CK7 in 7% of the cases. Pulmonary metastases of breast cancer were positive for GATA3 in 93% and CK7 in 78% of the cases, while 15% expressed CK5. Information on expression and patterns of immunohistochemical markers facilitates histopathological diagnostics. Evidently, unusual immune profiles occur and may lead to incorrect diagnosis.</AbstractText>                <CopyrightInformation>Copyright © 2018. Published by Elsevier Inc.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Vidarsdottir</LastName>                    <ForeName>Halla</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Surgery, Helsingborg Hospital, SE-251 87, Helsingborg, Sweden; Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 00 Lund, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Tran</LastName>                    <ForeName>Lena</ForeName>                    <Initials>L</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Genetics and Pathology, Division of Laboratory Medicine, Region Skåne, SE-221 85, Lund, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Nodin</LastName>                    <ForeName>Björn</ForeName>                    <Initials>B</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 00 Lund, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jirström</LastName>                    <ForeName>Karin</ForeName>                    <Initials>K</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 00 Lund, Sweden; Department of Genetics and Pathology, Division of Laboratory Medicine, Region Skåne, SE-221 85, Lund, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Planck</LastName>                    <ForeName>Maria</ForeName>                    <Initials>M</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 00 Lund, Sweden; Department of Respiratory medicine and Allergology, Skåne University Hospital, SE-221 85 Lund, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Jönsson</LastName>                    <ForeName>Per</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Sciences Lund, Division of Thoracic Surgery, Lund University, SE-221 00 Lund, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Mattsson</LastName>                    <ForeName>Johanna Sm</ForeName>                    <Initials>JS</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Botling</LastName>                    <ForeName>Johan</ForeName>                    <Initials>J</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Micke</LastName>                    <ForeName>Patrick</ForeName>                    <Initials>P</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Immunology, Genetics and Pathology, Uppsala University, SE-751 85 Uppsala, Sweden.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Brunnström</LastName>                    <ForeName>Hans</ForeName>                    <Initials>H</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Clinical Sciences Lund, Division of Oncology and Pathology, Lund University, SE-221 00 Lund, Sweden; Department of Genetics and Pathology, Division of Laboratory Medicine, Region Skåne, SE-221 85, Lund, Sweden. Electronic address: hans.brunnstrom@med.lu.se.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>10</Month>                <Day>30</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Hum Pathol</MedlineTA>            <NlmUniqueID>9421547</NlmUniqueID>            <ISSNLinking>0046-8177</ISSNLinking>        </MedlineJournalInfo>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">CDX2</Keyword>            <Keyword MajorTopicYN="N">Cytokeratin</Keyword>            <Keyword MajorTopicYN="N">GATA3</Keyword>            <Keyword MajorTopicYN="N">Napsin a</Keyword>            <Keyword MajorTopicYN="N">TTF-1</Keyword>            <Keyword MajorTopicYN="N">Tissue Microarray</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>08</Month>                <Day>16</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>09</Month>                <Day>30</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>10</Month>                <Day>01</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>11</Month>                <Day>4</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>11</Month>                <Day>6</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>aheadofprint</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30389437</ArticleId>            <ArticleId IdType="pii">S0046-8177(18)30396-4</ArticleId>            <ArticleId IdType="doi">10.1016/j.humpath.2018.10.009</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>